Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation

被引：0
|
作者：
Bayer, Ruthee-Lu [1 ]
Keyzner, Alla [1 ]
Donahue, Laura [1 ]
Elera, Claudia [1 ]
Roddy, Rose [1 ]
机构：
[1] N Shore Univ Hosp, Lake Success, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
130
引用
收藏
页码：S179 / S180
页数：2
相关论文
共 50 条
  • [1] Efficacy of Administration of Plerixafor (Mozobil®) at 5:00 PM for Stem Cell Mobilization (SCM) in Patients Receiving Autologous Stem Cell Transplant.
    Tornatta, Jennifer
    Maciejewski, John J.
    Nathan, Sunita
    McLeod, Bruce C.
    Rhoades, Darilyn
    Palaparthy, Sridevi
    Fung, Henry C.
    BLOOD, 2009, 114 (22) : 1247 - 1247
  • [2] EFFICACY OF PLERIXAFOR IN CD34+ STEM CELL MOBILIZATION IN HEALTHY PEDIATRIC STEM CELL DONORS
    Bharadwaj, Rishab
    Kumar, Vimal
    Munirathnam, Deenadayalan
    BONE MARROW TRANSPLANTATION, 2024, 59 : 644 - 644
  • [3] Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario
    Kouroukis, C. T.
    Varela, N. P.
    Bredeson, C.
    Kuruvilla, J.
    Xenocostas, A.
    CURRENT ONCOLOGY, 2016, 23 (04) : E409 - E430
  • [4] Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation
    Wang, Shirong
    Nademanee, Auayporn
    Qian, Dajun
    Dagis, Andrew
    Park, Hyun-Soon
    Fridey, Joy
    Smith, Eileen
    Snyder, David
    Somlo, George
    Stein, Anthony
    Rosenthal, Joseph
    Falk, Peter
    Kogut, Neil
    Palmer, Joycelynne
    Gaal, Karl
    Kim, Young
    Bhatia, Ravi
    Yuan, Shan
    Kay, Candace
    Weiss, Lawrence
    Forman, Stephen
    TRANSFUSION, 2007, 47 (12) : 2207 - 2216
  • [5] Peripheral hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang, Shirong
    Nademanee, Auayporn P.
    Qian, Dajun
    Dagis, Andrew
    Park, Hyun-Soon
    Fridey, Joy
    Smith, Eileen Patricia
    Snyder, David S.
    Bhatia, Ravi
    Falk, Peter M.
    Kay, Candace
    Kim, Young Sun
    Kogut, Neil Martin
    Palmer, Joycelynne
    Rosenthal, Joseph
    Somlo, George
    Stein, Anthony Selwyn
    Yuan, Shan
    Forman, Stephen J.
    BLOOD, 2006, 108 (11) : 453B - 453B
  • [6] Addition of plerixafor to stem cell mobilization regimens in autologous donors with multiple myeloma and lymphoma can increase the efficacy of stem cell harvesting in poor mobilizers
    Stuempel, J. -P
    Jentzsch, M.
    Ruschpler, E.
    Leiblein, S.
    Franke, G. -N
    Schwind, S.
    Jaekel, N.
    Wang, S. -Y
    Heyn, S.
    Poenisch, W.
    Niederwieser, D.
    Vucinic, V.
    Oncology Research and Treatment, 2015, 38 : 72 - 72
  • [7] Successful Hematopoietic Stem Cell Collection in Patients Who Fail Initial Plerixafor Mobilization for Autologous Stem Cell Transplant
    Veeraputhiran, Muthu
    Jain, Tania
    Cronin, Simon
    Al-Kadhimi, Zaid
    Abidi, Muneer H.
    Ayash, Lois
    Mellert, Kendra
    Lum, Lawrence G.
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    JOURNAL OF CLINICAL APHERESIS, 2014, 29 (06) : 293 - 298
  • [8] Plerixafor in myeloma and lymphoma patients undergoing autologous stem cell transplantation
    Zielinska, P.
    Markiewicz, M.
    Helbig, G.
    Mietla, M. Dzierzak
    Yrcz-Krzemien, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S347 - S347
  • [9] IV plerixafor combined with G-CSF is highly effective for stem cell mobilization in lymphoma patients undergoing autologous stem cell collection
    Cashen, A.
    Rettig, M.
    Gao, F.
    Reineck, T.
    Abboud, C.
    Stockerl-Goldstein, K.
    Vij, R.
    Uy, G.
    Westervelt, P.
    DiPersio, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S33 - S33
  • [10] Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant
    Tornatta, Jennifer
    Maciejewski, John J.
    Nathan, Sunita
    Mcleod, Bruce
    Palaparthy, Sridevi
    Rich, Elizabeth Shima
    Christopherson, Kent W., II
    Gregory, Stephanie A.
    Fung, Henry C.
    BLOOD, 2011, 118 (21) : 1734 - 1735
12345